Automated Blood Collection Systems Market By Product Type (Needles and Syringes, Blood Collection Tubes, Blood Bags, Lancets, and Others), By Application (Diagnostic Testing, Therapeutic Procedures, Blood Banking, and Research & Development), By Technology (Vacuum Blood Collection, Capillary Blood Collection, Syringe-Based Systems, and Point-of-Care Testing Devices), By End User (Hospitals, Diagnostic Laboratories, Blood Banks, Research Institutions and Home Care Settings), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Oct 2024 | Report ID: MI1110 | 215 Pages
Industry Outlook
The Automated Blood Collection Systems market accounted for USD 3.4 Billion in 2024 and is expected to reach USD 6.56 Billion by 2035, growing at a CAGR of around 6.15% between 2025 and 2035. Automated Blood Collection Systems include advanced technologies that streamline the process of blood collection for diagnostic testing and transfusions. Automated blood collection systems improve efficiency, reduce human error, and also enhance patient comfort by reducing the number of venipunctures. With this innovation comes the development of a self-sustaining mobile blood collection unit through automation, which could reach out-of-the-way places, and integration with electronic health records for easy data management. The other issues with advancements in robotics and AI are making it easier and more efficient to collect blood, coupled with real-time monitoring and adjustments being done as needed. As healthcare facilities look to become more efficient in the running of these facilities and to have better care for patients, the market is ready to take off by leaps and bounds.
Report Scope:
Parameter | Details |
---|---|
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2024 |
Market Size in 2024 | USD 3.4 Billion |
CAGR (2025-2035) | 6.15% |
Forecast Years | 2025-2035 |
Historical Data | 2018-2024 |
Market Size in 2035 | USD 6.56 Billion |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Switzerland, Sweden, Finland, Netherlands, Poland, Russia, China, India, Australia, Japan, South Korea, Singapore, Indonesia, Malaysia, Philippines, Brazil, Argentina, GCC Countries, and South Africa |
What We Cover | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PESTLE analysis, value chain analysis, regulatory landscape, pricing analysis by segments and region, company market share analysis, and over 10 companies |
Segments Covered | Product Type, Application, Technology, End User and Region |
To explore in-depth analysis in this report - Request Free Sample Report
Market Dynamics
Surging Demand for Blood Donations Drives Market Growth in Automated Blood Collection Systems
This high demand for blood donations is driving the growth of automated blood collection systems. Contributing factors to the increased demand are surgical procedures, an aging population, and greater awareness of the significance of blood donation. For instance, The World Health Organization estimates that 118.5 million blood donations are made annually throughout the world, underscoring the possibility of greater automation-based efficiency.
This creates stress on the hospitals and healthcare facilities that should ensure that they have sufficient stock of blood supplies; thus, more efficient methods of collection are in order. Automatic systems get the process of blood donation streamlined; it is faster, efficient, and safe, which motivates more people to donate blood. The government launching campaigns to enhance blood donations helps increase this pace. Due to this, higher demand for blood products increases the market for automated collection solutions soon to further develop the welfare of donors as well as health care providers.
Automation as a Key Driver for Growth in the Automated Blood Collection Systems Market
Most of the risks of contamination and human error are very critical in healthcare and are eliminated through automation in blood collection systems. Automated systems help standardize processes that reduce variability compared to purely manual handling. For instance, machines can use pre-packaged, pre-sterilized blood collection tubes. Samples will then be safe from contamination until the latter part of use. Direct human contact is also minimized, which could, in turn, prevent pathogens at the collection stage.
This accuracy will improve the safety and quality integrity of blood samples and assist towards more accurate diagnostics and patient outcomes. Their operational efficiency will thus improve with the enhanced safety and quality standards of the facility.
Rising Operational Costs Due to Maintenance and Technical Support Hinder Adoption of Automated Blood Collection Systems
Ongoing maintenance and technical support are major deterrents for the Automated Blood Collection Systems market because such costs significantly augment expenses related to operations. Automated systems require scheduled upkeep for efficient use and encompass elements like scheduled servicing, updating of the software, and replacement of some parts. Maintenance does not only prevent breakdowns but also, on compliance with safety and regulatory considerations, makes costs even more burdensome for healthcare facilities.
Staff may also need specific training to operate and troubleshoot such systems, which may be more expensive. Budget constraints also besiege most health organizations, and all the extra costs attached to operating automated blood collection systems might deter adoption in smaller facilities or developing countries. While automation may offer several long-term benefits, the extra cost initially and continually may be a major challenge to wide-scale adoption.
Emerging Opportunities in At-Home Blood Collection Systems for Enhanced Patient Convenience
Due to increased patient convenience and access, the opportunity for the market of automated blood collection systems is unlocked through the availability of home blood collection systems. The development in this respect allows patients to collect samples from the comfort of their own homes rather than requiring hospitalization and henceforth the discomfort related to traditional methods. These systems are normally supplied with friendly designs and easy, lucid instructions to follow, which thus facilitates easier blood collection by a person.
In-home solutions will also enable more regular and orderly checking of health conditions by making the patient take full responsibility for health care and helping them adhere to the schedule for testing. This may be very helpful in chronic disease management, where cyclic blood tests are taken.
Transforming Pediatric Blood Collection to Enhance Comfort and Compliance with Innovative Automated Systems
The design of automated blood collection systems targeted exclusively to pediatric patients would offer a rich possibility to improve young children's experiences through blood draws. Automated systems designed for pediatrics can be developed with child-friendly designs, distraction techniques like games or animations, and gentle collection methods to make the process less traumatic.
Improved comfort and interest will yield more compliance, encouraging even more families to carry out any required medical tests. Reducing anxieties associated with blood draws may also impact a child's perception about healthcare positively and will lead to better health outcomes in the long run. This niche market addresses a very critical need but simultaneously opens the doors for potential partnerships in pediatric healthcare providers and specialists.
Industry Experts Opinion
“We look forward to growing the business and transforming patient care with Sonder Capital, leveraging their expertise in successfully commercializing medical robotic technologies.”
- Toon Overbeeke, Co-founder and CEO of Vitestro
Segment Analysis
Based on the product type, the Automated Blood Collection Systems Market has been classified into needles and syringes, blood collection tubes, blood bags, lancets, and others. Blood collection tubes retain the top market share in the market for automated blood collection systems. Nevertheless, this mainly comes in as their application in clinical and laboratory contexts for multiple tests. Convenience, safety, and efficiency are key features of the Blood collection tube which made it gain popularity among healthcare professionals.
You can also buy individual sections of this report.
Would you like to review the price list for each section?
Based on the technology, the Automated Blood Collection Systems Market has been classified into vacuum blood collection, capillary blood collection, syringe-based systems, and point-of-care testing devices. The vacuum blood collection technology leads in the market share of automated blood collection systems. This method, though recognized for its efficiency and minimizing contamination, has been the standard in many clinical settings. Vacuum tubes are used for quick and safe blood volume collection in larger quantities, which is in essence needed for thorough testing.
Regional Analysis
In North America, there is a surge in the Automated Blood Collection Systems market due to growing demand for innovative healthcare solutions, especially in pediatric care. As healthcare providers have increasingly come to realize the need for child-friendly designs, the push for designing automated systems that make blood draws less traumatic and much more interesting for young patients is quite significant. For instance, as per CDC reports, the US healthcare system alone requires about 29,000 red blood cells, almost 5,000 units of platelets, and 6,500 units of plasma daily. Day in and day out this constant demand provides an enormous opportunity for an automated system that would make the process of collecting blood more efficient and safer.
The Asia Pacific regional landscape of the Automated Blood Collection Systems market is expanding rapidly with the spurt in healthcare investments and advancements in medical technology. The large and diverse population of the countries in this region is paying more emphasis on improving access to and efficiency of healthcare facilities. Due to the need for a less traumatic and more engaging experience of pediatric blood draws, innovative blood collection solutions particularly for pediatric patients have been in high demand among healthcare professionals. Also, awareness regarding the practice of safe collection and the importance of blood donation has been increasing within the population, which is fueling the growth of this market.
Competitive Landscape
The Automated Blood Collection Systems market features key players, including Terumo Corporation, Greiner Bio-One International GmbH, BD (Becton, Dickinson and Company), and Fresenius Kabi. All of these companies are active participants in bringing innovation to their product offerings. Such innovative developments include safety, efficiency, and the user experience. All these achievements allow these companies to remain leaders in a fast-moving business. Strategic partnerships and collaborations allow firms to leverage complementary strengths and expand their market reach.
For instance, In May 2022, Babson Diagnostics, a science-first, healthcare technology company, and BD (Becton, Dickinson and Company) a leading global medical technology company, announced the expansion of a strategic partnership that will lead blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing.
Automated Blood Collection Systems Market, Company Shares Analysis, 2024
To explore in-depth analysis in this report - Request Free Sample Report
Recent Developments:
- In September 2024, The Husky Technologies ™ and Kriya Medical Technologies Pvt. Ltd. have successfully deployed India's first integrated medical system, ICHOR ™. This pioneering collaboration further strengthens Kriya's facility in Chennai by making the facility capable of manufacturing 13×100 mm as well as 13×75 mm blood collection tubes.
- In August 2023, Terumo Blood and Cell Technologies (Terumo BCT) announced that it has received U.S. Food and Drug Administration (FDA) clearance for the Reveos Automated Whole Blood Processing System, an automated whole blood processing device for platelet and other component preparation from a single centrifugation cycle, providing a first in the United States.
Report Coverage:
By Product Type
- Needles and Syringes
- Blood Collection Tubes
- Blood Bags Lancets
- Others
By Application
- Diagnostic Testing
- Therapeutic Procedures
- Blood Banking
- Research and Development
By Technology
- Vacuum Blood Collection
- Capillary Blood Collection
- Syringe-Based Systems
- Point-of-Care Testing Devices
End User
- Hospitals
- Diagnostic Laboratories
- Blood Banks
- Research Institutions
- Home Care Settings
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- Terumo Corporation
- Becton, Dickinson and Company (BD)
- Fresenius Kabi
- Haemonetics Corporation
- Grifols S.A.
- Blood Centers of America
- Ortho Clinical Diagnostics
- Sysmex Corporation
- Roche Diagnostics
- Abbott Laboratories
- Cypress Diagnostics
- Kreative Technologies
- Nipro Corporation
- Beckman Coulter, Inc.
- Lifescan, Inc.
Frequently Asked Questions (FAQs)
The Automated Blood Collection Systems market accounted for USD 3.4 Billion in 2024 and is expected to reach USD 6.56 Billion by 2035, growing at a CAGR of around 6.15% between 2025 and 2035.
Key growth opportunities in the Automated Blood Collection Systems market include innovative automated systems that offer a much more conducive patient experience, and at-home blood collection systems, which further enhance convenience for patients by helping meet the increasing need for telehealth services.
Which are the largest and fastest-growing segments in the Automated Blood Collection Systems Market?
Product type is currently leading in the Automated Blood Collection Systems Market due to Blood collection tubes. This segment in healthcare mainly comes in as their application in clinical and laboratory contexts for multiple tests. Convenience, safety, and efficiency are key features of the Blood collection tube which made it gain popularity among healthcare professionals.
North American region is anticipated to contribute significantly towards the Automated Blood Collection Systems Market, which is based on the high level of adoption of advanced medical technologies. The comfort and safety of patients and the high prevalence of chronic diseases are adding to the growing demand for automated products in that region. Further investment in R&D also supports innovation and so it places North America at one of the forefront positions in the market.
The Asia-Pacific region is emerging rapidly as a key contributor to the automated blood collection systems market, based on an increase in access to healthcare and rising awareness of the importance of efficient blood collection. Since this growth is fueled by an increase in home healthcare services and improvements in technology, it fuels the growth of market growth in this region and makes this region a serious contender in this business.
Key operating players in the Automated Blood Collection Systems market are Fresenius Kabi, Terumo Corporation, Becton, Dickinson and Company (BD), Grifols, and Haemonetics Corporation. Leading the way in innovation, these companies keep improving their products to suit the changing demands of the healthcare industry.
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.